IHL 0.00% 4.1¢ incannex healthcare limited

General discussion, page-1985

  1. 1,080 Posts.
    lightbulb Created with Sketch. 186
    under the Australian SAS. Our long-term goal is represented by our multifaceted pharmaceutical research
    program being undertaken to pursue patents, and FDA registration, in up to 4 therapeutic products. 3 of
    those research programs have commenced studies and we expect more study results to be received and
    shared with our investors imminently”.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.